Company / Cash per Share
Harmony Biosciences Holdings, Inc. Cash per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$13.17
FY2025
5-year range
$4.12 / $13.17
FY2021-FY2025
Trend
+65.0%
vs FY2024
Sector context
#15 of 205
Health Care
What the data says
Among 205 Health Care companies, Harmony Biosciences Holdings, Inc. is in the top 7% for cash per share. Cash per Share has increased for 4 consecutive years, from $4.12 in FY2021 to $13.17 in FY2025.
Based on SEC 10-K filings.
13.17 in FY2025 with a 5-year CAGR of -14.8%. Top quartile in the Health Care sector.
Improved from $5.23 to $13.17 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +47.0%
- 5-Year CAGR
- -14.8%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 205This company $13.17 Sector average $67.98
▼
-80.6% below sector average
Key checks
Key Insights
- Harmony Biosciences Holdings, Inc.'s cash per share has grown for 4 consecutive years.
- In FY2025, cash per share increased 65.0% year-over-year.
- Ranks #15 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2020.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.17 | +65.0% |
| FY2024 | $7.98 | +52.6% |
| FY2023 | $5.23 | +26.1% |
| FY2022 | $4.14 | +0.6% |
| FY2021 | $4.12 | -86.0% |
| FY2020 | $29.36 | +833.6% |
| FY2019 | $3.14 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026